Patients with COPD and chronic hypercapnic respiratory failure on noninvasive ventilation report similar quality of life ...

Residents including parents of children who have received care for two conditions — asthma and chronic obstructive pulmonary disease — have been asked to assist in guiding the island’s healthcare ...

Obama officials omitted Russian intel on Hillary Clinton’s alleged health problems while saying Russian President Vladimir Putin aimed to help President Donald Trump, according to newly declassified ...

The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly ...

The pivotal Phase IIb ALIENTO study met its primary endpoint and showed that astegolimab reduced the annualized exacerbation rate (AER) by a statistically significant 15.4% at 52 weeks, when given ...

Astegolimab from Roche's Genentech fails phase 3 COPD trial, reflecting challenges in monoclonal antibody treatment for the ...

DEAR PEOPLE’S PHARMACY: My father has severe COPD. The doctors at the Department of Veterans Affairs hospital prescribed ...

Russia allegedly had intelligence suggesting that Hillary Clinton was taking "heavy tranquilizers," which President Obama and Democratic leaders found to be "extraordinarily alarming." ...

The fate of IL-33-targeting astegolimab will be determined by talks with regulators, after Roche AG’s Genentech unit rolled out mixed results from a pair of studies testing the compound vs. placebo on ...

Investigators concluded that biologic therapies reduced systemic glucocorticoid use in individuals with COPD and type 2 ...

Roche AG’s Genentech unit disclosed outcomes of two studies testing IL-33-targeting astegolimab vs. placebo on top of standard-of-care maintenance therapy in subjects with moderate to very severe ...

Digital inhalers can detect significant changes in physiologic and inhaler use metrics in the 14 days before COPD exacerbations.